TARGESOME INC has a total of 25 patent applications. Its first patent ever was published in 1996. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, measurement and micro-structure and nano-technology are GEBRO PHARMA GMBH, EHRLICH MARIKA and CELLENA AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Australia | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Canada | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Micro-structure and nano-technology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Nanostructure applications | |
#4 | Unspecified technologies | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Wartchow Charles Aaron | 20 |
#2 | Pease John S | 19 |
#3 | Dechene Neal Edward | 15 |
#4 | Bednarski Mark David | 14 |
#5 | Shen Zhi Min | 10 |
#6 | Li King Chuen | 9 |
#7 | Trulson Julie | 8 |
#8 | Sipkins Dorothy Anna | 5 |
#9 | Storrs Richard Wood | 5 |
#10 | Tropper Francois Daniel | 5 |
Publication | Filing date | Title |
---|---|---|
WO2004070009A2 | Targeted multivalent macromolecules | |
US2003082103A1 | Targeted therapeutic lipid constructs having cell surface targets | |
WO03028643A2 | Targeted therapeutic lipid constructs having cell surface targets | |
CA2455598A1 | Lipid constructs as therapeutic and imaging agents | |
US2003133972A1 | Targeted multivalent macromolecules | |
AU2002314861A1 | Targeted multivalent macromolecules | |
US2003129223A1 | Targeted multivalent macromolecules | |
CA2439953A1 | Stabilized therapeutic and imaging agents | |
AU1164902A | Targeted therapeutic agents | |
US6132764A | Targeted polymerized liposome diagnostic and treatment agents |